新出现市场报道时间 2026-10-09 03:10

集体诉讼已针对Beta Bionics, Inc.提起。

Schall, Brown & Schwartz LLP 已代表在 2025 年 7 月 30 日至 2026 年 2 月 24 日之间购买 BBNX 股票的投资者，就 Beta Bionics, Inc. 关于其 iLet 胰岛素泵的虚假和误导性陈述，向美国联邦证券机构提起了一项证券集体诉讼。

为什么重要. 在班级期间购买了Beta Bionics股份的投资者可能有资格获得赔偿，这会影响他们的财务利益。

影响到谁

PPR Newswire news releases公司披露2026-10-09 03:10
SBS brings together the extensive experience and diverse skillsets of founding partners Brian Schall, Andrew Brown, and David Schwartz.
查看来源
PPR Newswire news releases公司披露2026-10-09 03:10
Beta Bionics, Inc. ("Beta Bionics" or "the Company") (NASDAQ: BBNX) common stock
查看来源
PPR Newswire news releases公司披露2026-10-09 03:10
SBS attorneys are responsible for recovering over a billion dollars for violations of securities laws and corporate misfeasance.
查看来源
PPR Newswire news releases公司披露2026-10-09 03:10
Schall, Brown & Schwartz LLP represents investors around the world, specializing in securities class action lawsuits and shareholder rights litigation.
查看来源
PPR Newswire news releases公司披露2026-10-09 03:10
As the truth emerged, the price of Beta Bionics common stock declined
查看来源
PPR Newswire news releases公司披露2026-10-09 03:10
LOS ANGELES, Oct. 8, 2026 /PRNewswire/ -- Schall, Brown & Schwartz LLP, a national shareholder rights litigation firm, announces that it has filed a federal securities class action on behalf of purchasers of Beta Bionics, Inc. ("Beta Bionics" or "the Company") (NASDAQ: BBNX) com…
查看来源
PPR Newswire news releases公司披露2026-10-09 03:10
BBNX Investor Alert: Schall, Brown & Schwartz LLP Files Class Action Lawsuit Against Beta Bionics, Inc. and Announces Opportunity for Investors to Lead Class Action Lawsuit
查看来源